However, VSV-S significantly enhanced CD8+ T cell-mediated adaptive antitumor immunity, as evidenced by an increased number of tumor-infiltrating CD8+ T cells and their cytotoxicity compared to those observed following wtVSV infection. The gene discussed is CD8A; the disease is neoplasm.